InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the complete record of transactions filed by Lynn Baxter, President, Europe. Director active across 1 company, notably GSK plc. In total, 1 disclosures have been recorded. Activity tracked since 12 May 2026. The latest transaction was disclosed on 12 May 2026 (Purchase). Regulator: RNS (LSE). All data is free.
Declarations1 total
12 shares@ £18.7780.0000% mcap100.0% of flowLondon Stock Exchange (XLON)RNS:9569357-0
Ideal exit: 6 Feb 2027 (T+270)
1 of 1 declaration
About Lynn Baxter
Lynn Baxter is the Chief Executive Officer of GSK plc, overseeing operations in Europe. With extensive experience in the pharmaceutical sector, she is responsible for the company's strategy and overall direction. Her leadership is crucial for growth and innovation within GSK, a leading health company. She is committed to promoting sustainable health solutions and addressing patient needs worldwide.
